Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA and Arsenic Trioxide vs ATRA and Chemotherapy in Newly-diagnosed APL
NCT01987297Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jun 2012
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT01987297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987297.